Related Experiment Videos
The pre-ejection period as an antepartum indicator of fetal well-being
Insights
The pre-ejection period (PEP) shows promise as an antepartum indicator of fetal well-being. Corrected PEP (PEP140,40) may help predict fetal ability to withstand stress.
Area of Science:
- Perinatology
- Fetal Physiology
- Cardiovascular Assessment
Background:
- Assessing fetal well-being during pregnancy is crucial for optimal outcomes.
- Existing antepartum assessment methods have limitations in predicting fetal stress tolerance.
- The pre-ejection period (PEP) is a measure of cardiac function that may offer new insights.
Purpose of the Study:
- To evaluate the potential of the pre-ejection period (PEP) as an antepartum indicator of fetal well-being.
- To develop a method for correcting PEP for heart rate and gestational age.
- To assess the relationship between corrected PEP and fetal status.
Main Methods:
- PEP was measured in 108 subjects over a 2-year period.
- A correction equation (PEP140,40) was derived to standardize PEP for heart rate (140 bpm) and gestational age (40 weeks).
- PEP140,40 values were compared between a control group (95 fetuses) and fetuses classified as abnormal (13 fetuses).
Main Results:
- The derived equation was PEP140,40 = PEP + 0.36(FHR-140) + 1.4(40-GA).
- Normal PEP140,40 in the control group was 72.9 +/- 2.8 msec.
- Abnormal fetuses showed significant shortening (8/13) or prolongation (1/13) of PEP140,40 compared to normal fetuses.
Conclusions:
- Corrected PEP (PEP140,40) appears to be a useful indicator of fetal status and ability to withstand stress.
- PEP140,40 may enhance antenatal assessment when used with other parameters.
- Further studies with larger populations are needed to confirm these preliminary findings.
Abstract:
A preliminary study was made of the potential usefulness of the pre-ejection period (PEP) as an antepartum indicator of fetal well-being. PEP was evaluated in 108 subjects over a 2-year period. It is essential to correct for the effects of heart rate and gestational age on PEP before attempting to relate it ot fetal status. From the control group of 95 fetuses within our study, an equation to correct PEP to a standard heart rate of 140 beats per minute and gestational age of 40 weeks was derived: PEP140,40 = PEP + 0.36(FHR-140) + 1.4(40-GA). PEP140,40 for our control group was 72.9 +/- 2.8 msec. Of the 13 fetuses classified as abnormal in the study, four had a normal PEP140,40 eight showed significant shortening, and one had significant prolongation. These changes in PEP were related to underlying fetal status, and, when used together with other parameters of antenatal assessment, appear to be useful in predicting the ability of the fetus to withstand stress compatible with survival. Continuing evaluation on larger populations will be required to confirm the results of this study. The use of PEP140,40 is suggested as a valid method for comparing reports from different investigators.